Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Sleep Disorders
Mood Disorders
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2024
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Sleep Disorders
Mood Disorders
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2024
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Latest News
Find updates from Cogstate, leaders in the measurement of cognition.
Search
Show All
May 12, 2017
Cogstate Brief Battery Effective For Detecting Cognitive Impairment in Pediatric MS Patients
We use cookies to analyze our website traffic and to support technical features that enhance your user experience. Read our
Privacy
and
Cookie
Policies to learn more about how we use cookies.
Accept Cookies
Decline Cookies